
Berry supplements improve visual acuity
A blend of chokeberry, honeysuckle berry and bilberry extract improved near visual acuity and conjunctival hydration in presbyopic subjects, a Polish study found. The randomised, double-blind,

A blend of chokeberry, honeysuckle berry and bilberry extract improved near visual acuity and conjunctival hydration in presbyopic subjects, a Polish study found. The randomised, double-blind,

A new clinical study showed patients wearing Neurolenses had improved scores on a validated headache questionnaire. Using the Headache Impact Test (HIT) questionnaire, Neurolenses’ contoured-pr

Promising interim results from the phase 2 trial of Beacon Therapeutics' gene therapy to treat RP present a challenger to Luxturna.

Authors of a South Korean study found age-related macular degeneration (AMD) and certain cancers may share risk factors and pathogenic pathways.

Following the success of a University of Auckland-led pilot study examining castor oil as a treatment for dry eye disease, researchers are now looking for 90-plus participants for a larger, more robust study.

Japanese researchers from the Keio University School of Medicine in Tokyo, reported Bunazosin hydrochloride (BH), a commercial glaucoma eye drop that increases blood circulation in the eye, suppressed

A US company’s eye dropper-bottle adapter, which reduces standard doses by a fifth to 7-10µL, is being used by astronauts on board the International Space Station (ISS). Minnesota-based startup Nano

US researchers have developed a new protocol to triage potential eye-stroke patients, saying it will flag those at risk of brain stroke and help save vision. The protocol, developed by research

Research comparing the eye microbiotas of healthy individuals and those with dry eye disease (DED) has highlighted the potential roles of three bacterial species. Streptococcus and Pedobacter species

Children with amblyopia may have an increased risk of serious disease in adulthood, revealed a new UK study. Amblyopia could lead to hypertension, obesity and metabolic syndrome in adulthood, as well

Results of a phase 2 trial of Innovent’s anti-VEGF drug efdamrofusp alfa (IBI302) have shown it to be ‘non-inferior’ to Eylea (alibercept) in treating patients with neovascular age-related macular deg

US researchers have identified 87 genes susceptible to environmental influences affecting individuals’ risk of developing age-related macular degeneration (AMD). Led by Dr Anand Swaroop, senior